Zhou Mengxue, Wen Kaikai, Bi Ying, Lu Huiru, Chen Jun, Hu Yi, Chai Zhifang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, China.
Curr Top Med Chem. 2017;17(20):2319-2334. doi: 10.2174/1568026617666170224121008.
Nanocarriers are widely used for delivering drugs to tumors and are progressing in a stable trend, because malignant tumors remain a major health burden throughout the world and effective therapeutic strategies are urgently needed. Furthermore, as an integrated platform, nanocarriers have the potential to dramatically improve cancer diagnosis, imaging, and therapy, while reducing the toxicity associated with the current approaches. Significantly, intelligent nanocarriers are the new generation of the nanocarriers, exhibiting superior tumor targeting and improved therapeutic efficacy. In this review, we discuss recent development in the design of nanoscale stimuli-responsive systems which will be able to control drug biodistribution in response to specific stimuli, either exogenous or endogenous. Meanwhile, the recent progress in engineering intelligent and versatile nanomaterials for targeting the tumor microenvironment is summarized.
纳米载体被广泛用于将药物递送至肿瘤,并且正以稳定的趋势发展,因为恶性肿瘤仍然是全球主要的健康负担,迫切需要有效的治疗策略。此外,作为一个集成平台,纳米载体有潜力显著改善癌症诊断、成像和治疗,同时降低与当前方法相关的毒性。值得注意的是,智能纳米载体是新一代的纳米载体,具有卓越的肿瘤靶向性和更高的治疗效果。在本综述中,我们讨论了纳米级刺激响应系统设计的最新进展,该系统能够响应外源性或内源性的特定刺激来控制药物的生物分布。同时,总结了用于靶向肿瘤微环境的智能多功能纳米材料的最新进展。